SC
LAYN

Sophrosyne Capital’s Layne Christensen Co LAYN Stock Holding History

Sophrosyne Capital’s Portfolio LAYN Stock Details LAYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-10,500
Closed -$102K – 58
2014
Q3 		$102K Buy
+10,500
New +$119K 0.12% 51

Other funds holding LAYN

VDBMI
Van Den Berg Management I Austin, Texas $436M AUM 40.66% 1-Year Est. Return
RCM
Rutabaga Capital Management Boston, Massachusetts $115M AUM 11.85% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
KGI
Kopernik Global Investors Tampa, Florida $1.43B AUM 63.57% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
WAM
Water Asset Management New York $43.6M AUM 40.7% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Sophrosyne Capital's LAYN Position: Q4 2014 in Review

Sophrosyne Capital sold out of Layne Christensen Co (LAYN) in Q4 2014, closing a stake of 10,500 shares — an estimated $102K sold.

Sophrosyne Capital first reported a position in LAYN in Q3 2014 and held it in 1 quarter. The position peaked at $102K in Q3 2014. 85 funds tracked by Wall St. Rank hold LAYN as of Q4 2014.

  • Sophrosyne Capital reported no remaining Layne Christensen Co position as of Q4 2014 after selling out during the quarter.
  • Sophrosyne Capital sold 10,500 Layne Christensen Co shares in Q4 2014, an estimated $102K.
  • Sophrosyne Capital first reported a position in Layne Christensen Co in Q3 2014 and held it in 1 quarter.
  • Sophrosyne Capital's Layne Christensen Co position peaked at $102K in Q3 2014.
  • 85 funds tracked by Wall St. Rank held Layne Christensen Co as of Q4 2014.

Based on Sophrosyne Capital's 13F filing for Q4 2014, filed 26 Jan 2015.